Correlation Between Champions Oncology and Achilles Therapeutics
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Achilles Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Achilles Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Achilles Therapeutics PLC, you can compare the effects of market volatilities on Champions Oncology and Achilles Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Achilles Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Achilles Therapeutics.
Diversification Opportunities for Champions Oncology and Achilles Therapeutics
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Champions and Achilles is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Achilles Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achilles Therapeutics PLC and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Achilles Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achilles Therapeutics PLC has no effect on the direction of Champions Oncology i.e., Champions Oncology and Achilles Therapeutics go up and down completely randomly.
Pair Corralation between Champions Oncology and Achilles Therapeutics
Given the investment horizon of 90 days Champions Oncology is expected to generate 2.21 times more return on investment than Achilles Therapeutics. However, Champions Oncology is 2.21 times more volatile than Achilles Therapeutics PLC. It trades about 0.12 of its potential returns per unit of risk. Achilles Therapeutics PLC is currently generating about 0.22 per unit of risk. If you would invest 398.00 in Champions Oncology on August 29, 2024 and sell it today you would earn a total of 35.00 from holding Champions Oncology or generate 8.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Achilles Therapeutics PLC
Performance |
| Timeline |
| Champions Oncology |
| Achilles Therapeutics PLC |
Champions Oncology and Achilles Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Achilles Therapeutics
The main advantage of trading using opposite Champions Oncology and Achilles Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Achilles Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will offset losses from the drop in Achilles Therapeutics' long position.| Champions Oncology vs. Fonar | Champions Oncology vs. Burning Rock Biotech | Champions Oncology vs. Sera Prognostics | Champions Oncology vs. Exagen Inc |
| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |